Skip to main content
Click Here For COVID-19 Studies
Home
Clinical Trials Office Register as a Researcher Log In
338 Studies Now Enrolling
 Menu
Home How It Works Resources Join RecruitMe

Search

Reset

Status

  • Show all (9)
  • Currently Recruiting (4)
  • (-) Closed (5)

Medical Condition

  • Show all (1599)
  • Addiction (14)
  • Allergy, Asthma, & Immunology (12)
  • All of Us Research Program - NIH (1)
  • Autoimmune Disorders (26)
  • Blood Disorders (37)
  • Bone & Muscle (8)
  • Cancer (656)
    • Bladder Cancer (12)
    • Brain Cancer (16)
    • Breast Cancer (67)
    • Gastrointestinal (14)
    • Gynecologic Cancer (25)
    • Head and Neck Cancer (4)
    • Kidney Cancer (7)
    • Leukemia (71)
    • Liver Cancer (9)
    • Lung Cancer (60)
    • Lymphoma (36)
    • Multiple Myeloma (25)
    • Pancreatic Cancer (15)
    • Prostate Cancer (31)
    • Sarcoma (25)
    • Skin Cancer (30)
    • Solid Tumors (42)
    • (-) Thyroid Cancer (1)
    • Uveal Melanoma (7)
  • Child Development (4)
  • COVID-19 (Coronavirus) (28)
  • Critical Illness (1)
  • Dental (2)
  • Diabetes (15)
  • Ear, Nose and Throat (5)
  • Endocrine & Metabolic Disease (11)
  • Eye (7)
  • Gastrointestinal and Digestive Diseases (20)
  • Hair and Skin Disorders (1)
  • Headaches (5)
  • Healthy Volunteers (135)
  • Heart Disease (105)
  • Infectious Disease (35)
  • Insomnia (2)
  • Kidney Disease (12)
  • Liver Disease (34)
  • Lung Disease (29)
  • Meniere's Disease (1)
  • Neurological Disorders (134)
    • Alzheimer's Disease (31)
    • Brain Tumors (48)
    • Cerebral Palsy (1)
    • Dementia (5)
    • Huntington's Disease (2)
    • (-) Multiple Sclerosis (4)
    • Neuromuscular (8)
    • Neuropathy (11)
    • Parkinson's Disease (1)
  • Nutrition (5)
  • Obesity (2)
  • Obstetrics & Gynecology (40)
  • Pain Management (1)
  • Pediatrics (80)
  • Psychiatric Disorders (61)
  • Rehabilitation (7)
  • Stroke (6)
  • Surgery (7)
  • Transplant (37)
  • Urology (4)
  • Vascular Conditions (9)
Displaying 1 - 5 of 5

ProChocolate Study - Patients with Multiple Sclerosis (MS) and Family Members of Patients with MS

Condition: Neurological Disorders / Multiple Sclerosis
Investigator: Rebecca Straus Farber, MD
Status: Closed
We are currently recruiting individuals with Multiple Sclerosis (MS), first-degree family members of persons with MS, and healthy individuals to take part in our research on the effects of probiotics. Our goal is to better understand how the health of the gut microbiome influences the immune system.
Read More

Prebiotic vs. Probiotic Treatment in Multiple Sclerosis (MS) or Clinically Isolated Syndrome (CIS)

Condition: Neurological Disorders / Multiple Sclerosis
Investigator: Rebecca Straus Farber, MD
Status: Closed
This study will be used to evaluate the immunologic effects of Prebiotics (soluble fiber required by beneficial bacteria), in comparison to Probiotics (beneficial bacteria), in individuals with Multiple Sclerosis (MS) and Clinically Isolated Syndrome (CIS).
Read More

ASPIRE: Aspirin for Exercise in Multiple Sclerosis

Condition: Neurological Disorders / Multiple Sclerosis
Investigator: Victoria Leavitt, PhD
Status: Closed
ASPIRE is a clinical trial to investigate aspirin as a treatment to improve exercise performance in people with multiple sclerosis (MS) who experience overheating during exercise. Persons with multiple sclerosis benefit from exercise, but many avoid it because of exhaustion and overheating. This randomized controlled trial (RCT) tests aspirin as a method to…
Read More

A study for patients with Multiple Sclerosis (MS) using study drug ocrelizumab for disease-modifying treatment

Condition: Neurological Disorders / Multiple Sclerosis
Investigator: Claire Riley, MD
Status: Closed
The purpose of this study is to see if ocrelizumab (study drug) will stabilize, or potentiallyimprove the signs and symptoms of your MS. Ocrelizumab is a type of drug called amonoclonal antibody. Monoclonal antibodies act like your bodys immune system andattach to certain cells in order to attack germs and other illnesses in your body.Ocrelizumab attaches…
Read More

Ponatinib in Advanced or Metastatic Medullary Thyroid Cancer

Condition: Cancer / Thyroid Cancer
Investigator: Antonio Fojo, MD, PhD
Status: Closed
This is a study designed for patients with medullary thyroid cancer. Treatment will consist of a drug called Ponatinib. Ponatinib is an investigational agent that blocks abnormal cancer proteins and therefore harms cancer cells. It was recently approved by the Food and Drug Administration for leukemia treatment, but is not approved for medullary thyroid…
Read More
This website uses cookies as well as similar tools and technologies to understand visitors’ experiences. By continuing to use this website, you consent to Columbia University’s usage of cookies and similar technologies, in accordance with the Columbia University Website Cookie Notice.
I AGREE
COMPLIANCE
Compliance Hotline Compliance Program
RESOURCES
Contact RecruitMe Terms of Use Privacy Policy ©2025 Columbia University
SCHOOLS
Vagelos College of Physicians and Surgeons Mailman School of Public Health School of Nursing College of Dental Medicine Graduate School of Arts and Science